Carotid body tumor: characteristics and surgical outcome.
Carotid bifurcation
Carotid body tumor
Chemodectoma
Neuroendocrine tumor
Paraganglioma
Preoperative embolization
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
04
05
2024
accepted:
30
06
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
epublish
Résumé
Carotid body tumors are uncommon neuroendocrine growths near the carotid bifurcation. While some advocate preoperative embolization to minimize bleeding, others avoid it due to complications. This study shares the experience of a single center in managing patients with carotid body tumors without practicing preoperative embolization. This was a cross-sectional study of patients with carotid body tumors managed between 2020 and 2024. Data were collected from the hospital's registry. When necessary, routine blood tests, neck ultrasonography, and computed tomography scans were conducted. The tumors were categorized according to Shamblin's classification. The average duration of follow-up was 20 months. The study involved 25 patients, 22 (88%) females and 3 (12%) males. Their ages ranged from 27 to 85 years old. Twenty (80%) cases presented with neck swelling, and six (24%) had a positive medical history. Tumors were mainly on the right side (52%), with 20 (80%) showing ill-defined neck masses. Tumor sizes ranged from 1.5 to 7 cm, with Shamblin type II tumors being discovered in the majority of cases (72%). Types of tumors were significantly associated with the tumor size (p-value < 0.05). Blood transfusion was required in five cases (20%), three from type III and two from type II, with none from type I (p-value = 0.001). Temporary neurological deficits occurred in 3 cases (12%). No functional impairment or mortality was recorded. Carotid body tumors are rare tumors with an unknown etiology. Operation without practicing preoperative embolization may be feasible with an acceptable outcome.
Sections du résumé
BACKGROUND
BACKGROUND
Carotid body tumors are uncommon neuroendocrine growths near the carotid bifurcation. While some advocate preoperative embolization to minimize bleeding, others avoid it due to complications. This study shares the experience of a single center in managing patients with carotid body tumors without practicing preoperative embolization.
METHODS
METHODS
This was a cross-sectional study of patients with carotid body tumors managed between 2020 and 2024. Data were collected from the hospital's registry. When necessary, routine blood tests, neck ultrasonography, and computed tomography scans were conducted. The tumors were categorized according to Shamblin's classification. The average duration of follow-up was 20 months.
RESULTS
RESULTS
The study involved 25 patients, 22 (88%) females and 3 (12%) males. Their ages ranged from 27 to 85 years old. Twenty (80%) cases presented with neck swelling, and six (24%) had a positive medical history. Tumors were mainly on the right side (52%), with 20 (80%) showing ill-defined neck masses. Tumor sizes ranged from 1.5 to 7 cm, with Shamblin type II tumors being discovered in the majority of cases (72%). Types of tumors were significantly associated with the tumor size (p-value < 0.05). Blood transfusion was required in five cases (20%), three from type III and two from type II, with none from type I (p-value = 0.001). Temporary neurological deficits occurred in 3 cases (12%). No functional impairment or mortality was recorded.
CONCLUSIONS
CONCLUSIONS
Carotid body tumors are rare tumors with an unknown etiology. Operation without practicing preoperative embolization may be feasible with an acceptable outcome.
Identifiants
pubmed: 39085894
doi: 10.1186/s13019-024-02951-0
pii: 10.1186/s13019-024-02951-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
473Informations de copyright
© 2024. The Author(s).
Références
Hoang VT, Trinh CT, Lai K, T. A., et al. Carotid body tumor: a case report and literature review. J Radiol Case Rep. 2019;13(8):19–30.
doi: 10.3941/jrcr.v13i8.3681
pubmed: 31558967
pmcid: 6738487
Mingomataj E, Krasniqi M, Dedushi K, Sergeevich KA, Kust D, QadirA A. Cancer publications in one year (2023):a cross-sectional study. Barw Med J. 2024;2(1):3–11.
Knight TT Jr, Gonzalez JA, Rary JM, Rush DS. Current concepts for the surgical management of carotid body tumor. Am J Surg. 2006;191(1):104–10.
doi: 10.1016/j.amjsurg.2005.10.010
pubmed: 16399116
Mitchell RO, Richardson JD, Lambert GE. Characteristics, surgical management, and outcome in 17 carotid body tumors. Am Surg. 1996;62:1034. – 7.
pubmed: 8955243
Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732–9.
doi: 10.1016/0002-9610(71)90436-3
pubmed: 5127724
Najibi S, Terramani TT, Brinkman W, et al. Carotid body tumors. J Am Coll Surg. 2002;194:538–9.
doi: 10.1016/S1072-7515(02)01131-6
pubmed: 11949757
Kummer W, Yamamoto Y. Cellular distribution of oxygen sensor candidates— oxidases, cytochromes, K - channels—in the carotid body. Microsc Res Tech. 2002;59:234–42.
doi: 10.1002/jemt.10197
pubmed: 12384967
Wang X, Wang BR, Duan XL, et al. Strong expression of interleu- kin-1 receptor type I in the rat carotid body. J Histochem Cytochem. 2002;50:1677–84.
doi: 10.1177/002215540205001213
pubmed: 12486091
Ichikawa H. Innervation of the carotid body: immunohistochemical,denervation, and retrograde tracing studies. Microsc Res Tech. 2002;59:188. – 95.
doi: 10.1002/jemt.10193
pubmed: 12384963
Wang ZY, Bisgard GE. Chronic hypoxia-induced morphological and neurochemical changes in the carotid body. Microsc Res Tech. 2002;59:168–77.
doi: 10.1002/jemt.10191
pubmed: 12384961
Valdes V, Mosqueira M, Rey S, et al. Inhibitory effects of NO on carotid body: contribution of neural and endothelial nitric oxide synthase isoforms. Am J Physiol. 2003;284:L57–68.
Kontogeorgos G, Scheithauer BW, Kovacs K, et al. Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells. Endocr Pathol. 2002;13:197–206.
doi: 10.1385/EP:13:3:197
pubmed: 12446918
Maxwell JG, Jones SW, Wilson E, et al. Carotid body tumor excisions: adverse outcomes of adding carotid endarterectomy. J Am Coll Surg. 2004;198:36–41.
doi: 10.1016/j.jamcollsurg.2003.08.024
pubmed: 14698309
Baysal BE, Myers EN. Etiopathogenesis and clinical presentation of carotid body tumors. Microsc Res Tech. 2002;59(3):256–61.
doi: 10.1002/jemt.10200
pubmed: 12384970
Felbaum DR, Syed HR, McCullough MF, Armonda RA, Liu H, Bell RS. Embolization of Carotid Body Tumors: Revisiting Direct Puncture Technique, Preliminary Experience and Literature Review. Cureus. 2016;8(2).
Gonzalez-Urquijo M, Castro-Varela A, Barrios-Ruiz A, Hinojosa-Gonzalez DE, Garza Salas AK, Morales EA, González-González M, Fabiani MA. Current trends in carotid body tumors: Comprehensive review. Head Neck. 2022;44(10):2316–32.
doi: 10.1002/hed.27147
pubmed: 35838064
Abdullah HO, Abdalla BA, Kakamad FH, Ahmed JO, Baba HO, Hassan MN, et al. Predatory Publishing Lists: A Review on theOngoing Battle Against Fraudulent Actions. Barw Med J. 2024;2(2):26–30.
Sarookhani A, Chegini R. Carotid body tumor: our experience with 42 patients and a literature review. Indian J Otolaryngol Head Neck Surg. 2022;74(3):279–86.
doi: 10.1007/s12070-021-02453-8
pubmed: 36213462
Monabati A, Hodjati H, Kumar PV. Cytologic findings in carotid body tumors. Acta Cytol. 2002;46:1101–4.
doi: 10.1159/000327114
pubmed: 12462089
Stoeckli SJ, Schuknecht B, Alkadhi H, et al. Evaluation of paragangliomas presenting as a cervical mass on color-coded Doppler sonography. Laryngoscope. 2002;112:143–6.
doi: 10.1097/00005537-200201000-00025
pubmed: 11802053
Jiang X, Fang G, Guo D, et al. Surgical Management of Carotid Body Tumor and Risk factors of postoperative cranial nerve Injury. World J Surg. 2020;44:4254–60.
doi: 10.1007/s00268-020-05723-8
pubmed: 32804251
Jiazhang X, Yuejuan C, Hongyan Y, Guan Mei MD, Jia Ning, Bai Chunmei MD. Systemic treatment of a metastatic carotid body tumor: a case report and literature review. Medicine. 2020;99(47):e22811.
doi: 10.1097/MD.0000000000022811
Hu K, Persky MS. Multidisciplinary management of paragangliomas of the head and neck, part 1. Oncology. 2003;17:983–93.
pubmed: 12886866
Kim GY, Lawrence PF, Moridzadeh RS, Zimmerman K, Munoz A, Luna-Ortiz K, et al. New predictors of complications in carotid body tumor resection. J Vasc Surg. 2017;65(6):1673–9.
doi: 10.1016/j.jvs.2016.12.124
pubmed: 28527929
.Lamblin E, Atallah I, Reyt E, Schmerber S, Magne JL, Righini CA. Neurovascular complications following carotid body paraganglioma resection. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(5):319–24.
doi: 10.1016/j.anorl.2016.05.006
pubmed: 27297087